William Dawson
Director/Board Member bei MCGRATH RENTCORP
Vermögen: 3 Mio $ am 31.03.2024
Profil
William J.
Dawson is an Independent Director at McGrath RentCorp, Wellington Trust Co., NA, and Nalu Medical, Inc. He previously worked as Senior Vice President-Business Development at McKesson Corp., Chief Financial Officer & Vice President-Finance at Cerus Corp., Chief Financial Officer & VP-Operations at Dynavax Technologies Corp., Chief Financial Officer at Catalyst Bioscience, Inc., and Chief Financial & Accounting Officer at Adamas Pharmaceuticals LLC.
He also served as Acting Chief Financial Officer at iMcKesson LLC.
Dawson received his undergraduate degree from Stanford University in 1976 and his MBA from Harvard Business School in 1980.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MCGRATH RENTCORP
0,10% | 01.04.2024 | 24 000 ( 0,10% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von William Dawson
| Unternehmen | Position | Beginn |
|---|---|---|
| MCGRATH RENTCORP | Director/Board Member | 01.01.1998 |
Wellington Trust Co., NA
 Wellington Trust Co., NA Regional BanksFinance Part of Wellington Management Group LLP, Wellington Trust Co., NA is a financial institution that provides investment services. The private company is based in Boston, MA. The company's description emphasizes the risks associated with various asset classes and investment products. | Director/Board Member | 01.10.2001 |
Nalu Medical, Inc.
 Nalu Medical, Inc. Medical SpecialtiesHealth Technology Nalu Medical, Inc. is a medical technology company, which develops, manufactures, and commercializes invasive solutions for patients with chronic neuropathic pain. It markets Nalu neurostimulation system that delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The company was founded by Keegan Harper, Lee Hartley, Mike Partsch, and Daniel Pivonka in October 28, 2014 and is headquartered in Carlsbad, CA. | Director/Board Member | 01.01.2021 |
Ehemalige bekannte Positionen von William Dawson
| Unternehmen | Position | Ende |
|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.07.2017 |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 01.04.2012 |
| CERUS CORPORATION | Director of Finance/CFO | 30.04.2009 |
| DYNAVAX TECHNOLOGIES CORPORATION | Director of Finance/CFO | 01.08.2004 |
| MCKESSON CORPORATION | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von William Dawson
| Stanford University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MCGRATH RENTCORP | Finance |
| MCKESSON CORPORATION | Distribution Services |
| CERUS CORPORATION | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Wellington Trust Co., NA
Wellington Trust Co., NA Regional BanksFinance Part of Wellington Management Group LLP, Wellington Trust Co., NA is a financial institution that provides investment services. The private company is based in Boston, MA. The company's description emphasizes the risks associated with various asset classes and investment products. | Finance |
Catalyst Bioscience, Inc. /Old/
Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
| iMcKesson LLC | |
Nalu Medical, Inc.
Nalu Medical, Inc. Medical SpecialtiesHealth Technology Nalu Medical, Inc. is a medical technology company, which develops, manufactures, and commercializes invasive solutions for patients with chronic neuropathic pain. It markets Nalu neurostimulation system that delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The company was founded by Keegan Harper, Lee Hartley, Mike Partsch, and Daniel Pivonka in October 28, 2014 and is headquartered in Carlsbad, CA. | Health Technology |
